Neurology
Found 8 results
Filters: Author is Kang, Yeona  [Clear All Filters]
2021
Kang Y, Pandya S, Zinger N, Michaelson N, Gauthier SA.  2021.  Longitudinal change in TSPO PET imaging in progressive multiple sclerosis.. Ann Clin Transl Neurol.
2020
Kang Y, Rúa SMilena Hur, Kaunzner UW, Perumal J, Nealon N, Qu W, Kothari PJ, Vartanian T, Kuceyeski A, Gauthier SA.  2020.  A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis.. Mol Imaging Biol.
2019
Kang Y, Henchcliffe C, Verma A, Vallabhajosula S, He B, Kothari PJ, Pryor KO, P Mozley D.  2019.  18F-FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease.. J Neuroimaging. 29(1):97-103.
Kang Y, Gauthier SA.  2019.  PET is necessary to make the next step forward in understanding MS pathophysiology - Commentary.. Mult Scler. 25(8):1090-1091.
Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Rúa SMHurtado, Park C, Gillen KM, Nguyen TD et al..  2019.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.. Brain. 142(1):133-145.
2018
Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA.  2018.  Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.. PLoS One. 13(8):e0201289.
Kang Y, P Mozley D, Verma A, Schlyer D, Henchcliffe C, Gauthier SA, Chiao PC, He B, Nikolopoulou A, Logan J et al..  2018.  Noninvasive PK11195-PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease.. J Neuroimaging. 28(5):496-505.
2017
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.